NKTX - Nkarta, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
South San Francisco,
United States
Type: Equity
NKTX price evolution
NKTX
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $33.78 | $41.01 | $31.86 | $56.41 |
| Short term investments | $217.15 | $237.35 | $251.64 | $269.68 |
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $253.07 | $281.19 | $286.74 | $332.19 |
| Long term investments | $18.73 | $6.02 | ||
| Property, plant & equipment | $119.28 | $118.21 | $117.17 | $115.35 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $125.81 | $124.68 | $142.3 | $125.98 |
| Total investments | $217.15 | $237.35 | $270.36 | $275.69 |
| Total assets | $378.88 | $405.86 | $429.04 | $458.17 |
| Current liabilities | ||||
| Accounts payable | $3.67 | $4.28 | $3.01 | $5.41 |
| Deferred revenue | ||||
| Short long term debt | $6.07 | $6.06 | $6.05 | $5.75 |
| Total current liabilities | $23.33 | $25.64 | $26.61 | $25.98 |
| Long term debt | $82.27 | $83.41 | $84.45 | $85.54 |
| Total noncurrent liabilities | $82.27 | $83.41 | $84.45 | $85.54 |
| Total debt | $88.34 | $89.47 | $90.5 | $91.29 |
| Total liabilities | $105.6 | $109.05 | $111.06 | $111.52 |
| Shareholders' equity | ||||
| Retained earnings | -$435.43 | -$407.68 | -$382.04 | -$348.75 |
| Other shareholder equity | $0.01 | -$0.41 | -$0.6 | -$0.17 |
| Total shareholder equity | $273.29 | $296.82 | $317.98 | $346.65 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $33.78 | $40.24 | $62.91 | $97.11 |
| Short term investments | $217.15 | $314.65 | $177.27 | $218.22 |
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $253.07 | $360.69 | $245.78 | $318.83 |
| Long term investments | ||||
| Property, plant & equipment | $119.28 | $107.66 | $24.53 | $17.86 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $125.81 | $112.25 | $28.12 | $18.82 |
| Total investments | $217.15 | $314.65 | $177.27 | $218.22 |
| Total assets | $378.88 | $472.94 | $273.9 | $337.65 |
| Current liabilities | ||||
| Accounts payable | $3.67 | $1.76 | $1.11 | $1.18 |
| Deferred revenue | ||||
| Short long term debt | $6.07 | $4.25 | $2.48 | $1.4 |
| Total current liabilities | $23.33 | $22.05 | $12.94 | $8.83 |
| Long term debt | $82.27 | $78.69 | $9.97 | $7.52 |
| Total noncurrent liabilities | $82.27 | $78.69 | $9.99 | $7.6 |
| Total debt | $88.34 | $82.93 | $12.46 | $8.92 |
| Total liabilities | $105.6 | $100.73 | $22.94 | $16.43 |
| Shareholders' equity | ||||
| Retained earnings | -$435.43 | -$317.93 | -$204.1 | -$118.02 |
| Other shareholder equity | $0.01 | -$0.68 | -$0.15 | $0 |
| Total shareholder equity | $273.29 | $372.21 | $250.97 | $321.22 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $23.32 | $22.19 | $25.12 | $26.14 |
| Selling, general & administrative | $7.86 | $7.1 | $11.74 | $8.18 |
| Total operating expenses | $31.18 | $29.29 | $36.86 | $34.31 |
| Operating income | -$31.18 | -$29.29 | -$36.86 | -$34.31 |
| Income from continuing operations | ||||
| EBIT | -$27.75 | -$25.64 | -$33.29 | -$30.82 |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | -$27.75 | -$25.64 | -$33.29 | -$30.82 |
| Income (for common shares) | -$27.75 | -$25.64 | -$33.29 | -$30.82 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | $96.77 | $90.9 | $63.41 | $36.22 |
| Selling, general & administrative | $34.88 | $28.06 | $23.02 | $15.29 |
| Total operating expenses | $131.65 | $118.95 | $86.43 | $51.51 |
| Operating income | -$131.65 | -$118.95 | -$86.43 | -$51.51 |
| Income from continuing operations | ||||
| EBIT | -$117.5 | -$113.84 | -$86.08 | -$91.36 |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | -$117.5 | -$113.84 | -$86.08 | -$91.36 |
| Income (for common shares) | -$117.5 | -$113.84 | -$86.08 | -$91.36 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$27.75 | -$25.64 | -$33.29 | -$30.82 |
| Operating activities | ||||
| Depreciation | $2.82 | $2.54 | $1.39 | $1.34 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $3.51 | $4.29 | $4.65 | $4.75 |
| Total cash flows from operations | -$23.35 | -$20.27 | -$21.77 | -$20.76 |
| Investing activities | ||||
| Capital expenditures | -$6.81 | -$6.19 | -$10.33 | -$4.82 |
| Investments | $22.64 | $35.61 | $7.16 | $41.75 |
| Total cash flows from investing | $15.84 | $29.42 | -$3.17 | $36.93 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.29 | $0.4 | $0 | |
| Net borrowings | ||||
| Total cash flows from financing | $0.29 | $0.4 | $0 | |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$7.22 | $9.14 | -$24.55 | $16.17 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$117.5 | -$113.84 | -$86.08 | -$91.36 |
| Operating activities | ||||
| Depreciation | $8.09 | $6.57 | $2.12 | $1.05 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $17.2 | $16.86 | $14.46 | $6.75 |
| Total cash flows from operations | -$86.16 | -$57 | -$67.93 | -$43.51 |
| Investing activities | ||||
| Capital expenditures | -$28.15 | -$47.11 | -$5.03 | -$7.51 |
| Investments | $107.16 | -$137.58 | $37.56 | -$202.57 |
| Total cash flows from investing | $79.02 | -$184.69 | $32.53 | -$210.08 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.69 | $219.01 | $1.48 | $265.5 |
| Net borrowings | ||||
| Total cash flows from financing | $0.69 | $219.01 | $1.2 | $329.82 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$6.45 | -$22.68 | -$34.19 | $76.23 |
News
Fundamentals
| Market cap | $352.63M |
|---|---|
| Enterprise value | $407.19M |
| Shares outstanding | 49.18M |
| Revenue | $0.00 |
|---|---|
| EBITDA | -$109.41M |
| EBIT | -$117.50M |
| Net Income | -$117.50M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -3.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | -3.72 |
| EV/EBIT | -3.47 |
| P/S ratio | N/A |
| P/B ratio | 1.29 |
| Book/Share | 5.56 |
| Cash/Share | 0.69 |
| EPS | -$2.39 |
|---|---|
| ROA | -28.11% |
| ROE | -38.07% |
| Debt/Equity | 0.39 |
|---|---|
| Net debt/EBITDA | -0.66 |
| Current ratio | 10.85 |
| Quick ratio | 10.85 |